Beijing Andawell Science & Technology Co., Ltd. (SHE:300719)
12.75
+0.06 (0.47%)
Jun 23, 2026, 3:04 PM CST
SHE:300719 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
| 653.42 | 679.63 | 632.79 | 850.86 | 412.55 | 475.46 | |
Revenue Growth (YoY) | -0.90% | 7.40% | -25.63% | 106.25% | -13.23% | -22.02% |
Cost of Revenue | 407.66 | 423.23 | 374.69 | 471.27 | 252.93 | 256.89 |
Gross Profit | 245.76 | 256.4 | 258.1 | 379.59 | 159.61 | 218.57 |
Selling, General & Admin | 172 | 174.82 | 171.07 | 173.69 | 153.55 | 151.35 |
Research & Development | 79.29 | 81.99 | 82.2 | 66.68 | 69.49 | 70.16 |
Other Operating Expenses | 2.53 | 2.4 | -11.67 | -3.55 | -14.53 | -7.9 |
Operating Expenses | 263.12 | 266.76 | 248.69 | 251.17 | 224.01 | 210.34 |
Operating Income | -17.36 | -10.36 | 9.41 | 128.42 | -64.4 | 8.22 |
Interest Expense | -10.64 | -11 | -7.25 | -4.12 | -3.11 | -4.37 |
Interest & Investment Income | 0.78 | 0.99 | 1.8 | 2.42 | 1.67 | 1.55 |
Currency Exchange Gain (Loss) | -0.01 | -0.01 | 0 | 0.02 | 0 | -0.01 |
Other Non Operating Income (Expenses) | -1.89 | -0.83 | -1.2 | -1.25 | -0.48 | -0.62 |
EBT Excluding Unusual Items | -29.12 | -21.21 | 2.77 | 125.49 | -66.3 | 4.77 |
Gain (Loss) on Sale of Investments | - | -0 | 0 | -0.01 | - | -1.2 |
Gain (Loss) on Sale of Assets | 0.9 | 0.27 | 4.94 | -0.21 | 0.48 | -0.04 |
Asset Writedown | -0.04 | -0.23 | -0.22 | -0.09 | -0.3 | -0.14 |
Other Unusual Items | 3.74 | 3.74 | -2.23 | -0.27 | 3.53 | 0.95 |
Pretax Income | -24.52 | -17.42 | 5.26 | 124.9 | -62.58 | 4.34 |
Income Tax Expense | -11.43 | -9.63 | -7.45 | 11.41 | -16.77 | -6.09 |
Earnings From Continuing Operations | -13.09 | -7.79 | 12.7 | 113.49 | -45.82 | 10.43 |
Minority Interest in Earnings | 1.77 | 2.09 | 1.12 | -0.01 | - | - |
Net Income | -11.33 | -5.7 | 13.83 | 113.48 | -45.82 | 10.43 |
Net Income to Common | -11.33 | -5.7 | 13.83 | 113.48 | -45.82 | 10.43 |
Net Income Growth | - | - | -87.81% | - | - | -89.08% |
Shares Outstanding (Basic) | 254 | 254 | 255 | 255 | 254 | 254 |
Shares Outstanding (Diluted) | 254 | 254 | 255 | 255 | 254 | 254 |
Shares Change (YoY) | -0.36% | -0.29% | -0.05% | 0.34% | 0.04% | 0.01% |
EPS (Basic) | -0.04 | -0.02 | 0.05 | 0.44 | -0.18 | 0.04 |
EPS (Diluted) | -0.04 | -0.02 | 0.05 | 0.44 | -0.18 | 0.04 |
EPS Growth | - | - | -87.81% | - | - | -89.08% |
Free Cash Flow | -65.36 | -37.45 | -270.91 | 12.01 | -36.6 | 119.55 |
Free Cash Flow Per Share | -0.26 | -0.15 | -1.06 | 0.05 | -0.14 | 0.47 |
Dividend Per Share | - | - | 0.040 | 0.200 | - | 0.020 |
Dividend Growth | - | - | -80.00% | - | - | -90.00% |
Gross Margin | 37.61% | 37.73% | 40.79% | 44.61% | 38.69% | 45.97% |
Operating Margin | -2.66% | -1.52% | 1.49% | 15.09% | -15.61% | 1.73% |
Profit Margin | -1.73% | -0.84% | 2.19% | 13.34% | -11.11% | 2.19% |
Free Cash Flow Margin | -10.00% | -5.51% | -42.81% | 1.41% | -8.87% | 25.14% |
EBITDA | -2.71 | 4.62 | 25.69 | 141.86 | -47.68 | 23.65 |
EBITDA Margin | -0.41% | 0.68% | 4.06% | 16.67% | -11.56% | 4.97% |
D&A For EBITDA | 14.65 | 14.98 | 16.28 | 13.44 | 16.72 | 15.43 |
EBIT | -17.36 | -10.36 | 9.41 | 128.42 | -64.4 | 8.22 |
EBIT Margin | -2.66% | -1.52% | 1.49% | 15.09% | -15.61% | 1.73% |
Effective Tax Rate | - | - | - | 9.14% | - | - |
Revenue as Reported | 653.42 | 679.63 | 632.79 | 850.86 | 412.55 | 475.46 |
Advertising Expenses | - | 1.33 | 1.65 | 1.24 | 0.23 | 0.92 |